系统性红斑狼的新机制和治疗点
Jingru Tian1,2,3,4, Hang Zhou1,2,3, Wei Li5
1Hospital for Skin Diseases Institute of Dermatology Chinese Academy of Medical Sciences and Peking Union Medical College Nanjing China.
MedComm
|June 10, 2025
概括
系统性红斑狼 (SLE) 涉及遗传,环境和性别因素,I型干扰素和自身抗体驱动炎症. 像树突细胞和单细胞这样的先天性免疫细胞的早期不稳定是SLE病原体的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
- 类风湿病学 类风湿病学
背景情况:
- 系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病.
- 病原发生涉及遗传,环境和与性别有关的因素.
- I型干扰素 (IFN-I) 和自身抗体是SLE病变的核心.
研究的目的:
- 综合最近的流行病学发现和SLE的致病机制.
- 突出对疾病触发因素和早期病理过程的新兴见解.
- 确定潜在的治疗目标和临床研究的进展.
主要方法:
- 关于SLE病变的当前文献的综述.
- 综合流行病学数据.
- 对最近的翻译和临床研究进行分析.
主要成果:
- 天生的免疫细胞 (树突细胞,单细胞) 不稳定是SLE的关键早期事件.
- 敏感个体的环境触发因素会启动持续的免疫激活.
- 了解早期免疫失调对于向治疗至关重要.
结论:
- SLE的发病因子是多因素的,早期的先天性免疫细胞变化起着重要作用.
- 对触发因素和早期事件的进一步研究可以导致SLE的精确,基于机制的治疗方法.
- 本综述巩固了最近的进展,以完善理解和指导治疗策略.
相关概念视频
Autoimmune Disorders
394
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
394
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959
Antiasthma Drugs: Leukotriene Modifiers
249
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
249


